Lifecore Biomedical Inc (NASDAQ: LFCR) stock suffered a major decline of -11.0% on 9/20/24. The shares closed at $5.00. Moreover, trading volume in this decline was above average at 147% of normal. The stock has been extremely weak relative to the market over the last nine months and has declined -2.3% during the last week.
Current PriceTarget Research Rating
LFCR’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.
Lifecore Biomedical has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Lifecore Biomedical has a very low Power Rating of 10 and a very low Appreciation Score of 1, producing the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment